Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Files An 8-K Results of Operations and Financial ConditionItem 2.02Results of Operations and Financial Condition.
On April 10, 2018, the Company issued a press release announcing unaudited, preliminary financial results for the quarter ended March 31, 2018.A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
The unaudited financial results for the quarter ended March 31, 2018 contained in the press release are preliminary and subject to adjustment.The final, unaudited financial results will be included in the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2018 to be filed with the Securities and Exchange Commission.
The information provided under this Item 2.02, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed” for the purposes of Section18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 2.02Financial Statements and Exhibits
TANDEM DIABETES CARE INC ExhibitEX-99.1 2 tndm-ex991_6.htm EX-99.1 PRESS RELEASE tndm-ex991_6.htm Exhibit 99.1 Media Contact: Steve Sabicer 714-907-6264 [email protected] Investor Contact: Susan Morrison 858-366-6900 x7005 [email protected] FOR IMMEDIATE RELEASE Tandem Diabetes Care Announces Preliminary First Quarter 2018 Results San Diego,…To view the full exhibit click here
About Tandem Diabetes Care, Inc. (NASDAQ:TNDM)
Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump’s cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.
